当前位置:首页 - 行情中心 - 九强生物(300406) - 财务分析 - 资产负债表

九强生物

(300406)

  

流通市值:72.09亿  总市值:100.45亿
流通股本:4.22亿   总股本:5.88亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金724,037,812.52402,913,980.64306,479,176.77321,963,005.37
应收票据及应收账款1,144,627,815.041,120,850,292.621,112,482,068.61,084,699,869.61
其中:应收票据43,599,289.9329,652,626.7924,530,714.4520,852,670.6
应收账款1,101,028,525.111,091,197,665.831,087,951,354.151,063,847,199.01
预付款项19,631,693.3656,512,103.673,496,023.565,593,671.39
其他应收款合计7,898,381.0214,249,709.5313,480,160.6914,064,037.67
存货229,744,758.87230,194,037.42219,418,622.46241,202,629.9
一年内到期的非流动资产205,453,400.82522,033,045.41451,625,345.45383,232,364.89
其他流动资产2,872,635.7501,158.78672,639.61911,627.53
流动资产平衡项目0000
流动资产合计2,334,266,497.332,347,254,3282,177,654,037.082,111,667,206.36
非流动资产:
长期应收款26,298,121.3714,154,394.2513,850,487.57,677,585.25
其他权益工具投资30,000,00030,000,00030,000,00030,000,000
固定资产337,471,459.51341,423,447.46348,386,807.36354,982,166.33
在建工程211,029,079.01164,588,945.01129,470,134.16106,944,633.64
使用权资产6,739,394.022,930,946.073,554,925.113,194,541.97
无形资产60,488,426.2760,132,445.5861,763,673.7163,764,952.89
商誉1,672,545,682.471,672,545,682.471,672,545,682.471,672,545,682.47
长期待摊费用2,846,832.143,113,501.013,288,506.593,105,040.14
递延所得税资产45,852,089.7738,734,438.4338,734,438.4437,718,666.63
其他非流动资产448,211,224.43291,721,361.09317,601,087.32295,422,687.32
非流动资产平衡项目0000
非流动资产合计2,841,482,308.992,619,345,161.372,619,195,742.662,575,355,956.64
资产平衡项目0000
资产总计5,175,748,806.324,966,599,489.374,796,849,779.744,687,023,163
流动负债:
短期借款-7,601,792.4658,421,901.5859,703,565.42
应付票据及应付账款81,707,528.2952,489,150.3647,037,153.7647,587,058.81
其中:应付票据8,433,821.513,504,023.811,600,617.32,414,670
应付账款73,273,706.7938,985,126.5635,436,536.4645,172,388.81
预收款项3,552,630.544,291,834.671,155,729.38968,388.87
合同负债15,401,374.5816,095,903.8117,872,964.5420,507,891.01
应付职工薪酬76,807,778.4645,639,122.3329,287,224.4413,925,933.41
应交税费37,015,944.5234,979,420.4627,402,020.9436,744,120.04
其他应付款合计69,427,930.0785,175,738.338,119,570.1939,861,346.23
一年内到期的非流动负债3,968,448.595,089,763.814,056,582.736,487,773.45
其他流动负债9,234,143.025,219,951.486,877,871.76,409,607.02
流动负债平衡项目0000
流动负债合计297,115,778.07256,582,677.68230,231,019.26232,195,684.26
非流动负债:
长期借款134,765,562.85129,040,649.76100,879,702.3371,836,494.82
应付债券991,981,141.6981,978,312.3972,188,368.41977,498,453.29
租赁负债4,913,582.97532,214.39645,328.91787,070.51
递延收益16,973,999.417,391,807.3417,810,741.7818,230,046.26
递延所得税负债8,448,584.798,864,522.169,173,644.029,357,032.29
非流动负债平衡项目0000
非流动负债合计1,157,082,871.611,137,807,505.951,100,697,785.451,077,709,097.17
负债平衡项目0000
负债合计1,454,198,649.681,394,390,183.631,330,928,804.711,309,904,781.43
所有者权益(或股东权益):
实收资本(或股本)588,445,628588,445,404589,866,087588,846,703
其他权益工具176,853,455.82176,854,076.01176,854,689.95179,673,843.74
资本公积399,953,046.57392,053,079.56410,505,616.43391,516,849.42
减:库存股109,588,377.9495,326,687.2892,790,529.5393,072,437.13
其他综合收益450,086.72594,247.24667,117.49107,019.05
盈余公积280,464,487.72259,460,106.6259,460,106.6249,622,267.77
未分配利润2,388,013,582.872,256,616,488.312,126,867,258.292,064,756,242.6
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计3,724,591,909.763,578,696,714.443,471,430,346.233,381,450,488.45
少数股东权益-3,041,753.12-6,487,408.7-5,509,371.2-4,332,106.88
股东权益平衡项目0000
股东权益合计3,721,550,156.643,572,209,305.743,465,920,975.033,377,118,381.57
负债和股东权益合计5,175,748,806.324,966,599,489.374,796,849,779.744,687,023,163
公告日期2024-03-302023-10-252023-08-102023-04-28
审计意见(境内)标准无保留意见
TOP↑